FDA Inspection
Galephar Pharmaceutical Research Inc.Galephar Pharmaceutical Research Inc. – FDA Inspection, Oct 18, 2024
Record Details
This FDA Inspection record concerns Galephar Pharmaceutical Research Inc., with an inspection on October 18, 2024, issued by the San Juan District Office, covering human drugs.
View Company Profile
ID · f30929e1-c1b3-4022-a855-84862f621769
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1252181
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.188(b)(12)Investigations made into any unexplained discrepancy
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Galephar Pharmaceutical Research Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| October 24, 2018 | Not classified | San Juan District Office | |
| November 23, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 29, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 4, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 30, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Galephar Pharmaceutical Research Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.